The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs

OBJECTIVE: This study aimed to identify a predictive marker of response to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with EGFR-mutant advanced lung adenocarcinoma. METHODS: A cohort of 190 patients with EGFR-mutant advanced lung adenocarcinoma was analyzed....

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qiong, Li, Yamin, Zhou, Xihong, Zhou, Wen, Xia, Chunfang, Zhang, Ruzhe, Zhang, Zhengjie, Hu, Aiyang, Peng, Siyin, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020225/
https://www.ncbi.nlm.nih.gov/pubmed/33794676
http://dx.doi.org/10.1177/03000605211004021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020225/
https://www.ncbi.nlm.nih.gov/pubmed/33794676
http://dx.doi.org/10.1177/03000605211004021

Ejemplares similares